Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 3Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 1408Neoplasms 1142Prostatic Neoplasms 750Lung Neoplasms 626Colorectal Neoplasms 604Carcinoma, Non-Small-Cell Lung 574Carcinoma, Hepatocellular 414Pancreatic Neoplasms 410Leukemia, Myeloid, Acute 399Stomach Neoplasms 365Multiple Myeloma 324Ovarian Neoplasms 313Brain Neoplasms 313Head and Neck Neoplasms 289Neoplasm Metastasis 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 263Rectal Neoplasms 257Recurrence 253Uterine Cervical Neoplasms 249Melanoma 245Esophageal Neoplasms 244Squamous Cell Carcinoma of Head and Neck 236Glioblastoma 232Lymphoma 214Sarcoma 209Colonic Neoplasms 195Urinary Bladder Neoplasms 194Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 186

Interventions

tislelizumab 1Rutin 1Neoadjuvant Therapy 1Gemcitabine 1Cystectomy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Muscle Invasive Bladder Cancer × Clear all
NCT07202819 2025-10-02

"NAC-MRI"

Assiut University

Phase NA Recruiting
76 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

NCT06916494 2025-04-10

Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer

First Affiliated Hospital of Chongqing Medical University

Phase 1 Recruiting
10 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡